Score Overview
Explore the 2021 public Archive ranking →
Where Boston Scientific Corp has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- BSX
2003: 35.4% · 2021: 42.1% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 44.11 | — |
1 Year2025-09-26 | $ 98.18 | -55.07% |
5 Years2021-09-28 | $ 43.67 | 1.01% |
10 Years2016-09-28 | $ 23.75 | 85.73% |
20 Years2006-09-28 | $ 14.77 | 198.65% |
30 Years1996-09-27 | $ 14.03 | 214.37% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 |
|---|---|---|---|---|---|---|
| Price | $ 44.11 | $ 98.18 | $ 43.67 | $ 23.75 | $ 14.77 | $ 14.03 |
| Return | — | -55.07% | 1.01% | 85.73% | 198.65% | 214.37% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 20.99B | $ 3.67B | |
| 2025 | $ 20.07B | $ 2.88B | $ 2.04B |
| 2024 | $ 16.74B | $ 1.85B | $ 414M |
| 2023 | $ 14.24B | $ 1.59B | $ 865M |
| 2022 | $ 12.68B | $ 698M | $ 928M |
| 2021 | $ 11.88B | $ 1.04B | $ 1.92B |
| 2020 | $ 9.91B | -$ 82M | $ 1.73B |
| 2019 | $ 10.73B | $ 4.70B | $ 217M |
| 2018 | $ 9.82B | $ 1.67B | $ 146M |
| 2017 | $ 9.04B | $ 104M | $ 188M |
| 2016 | $ 8.38B | $ 347M | $ 196M |
| 2015 | $ 7.47B | -$ 239M | $ 319M |
| 2014 | $ 7.38B | -$ 119M | $ 587M |
| 2013 | $ 7.14B | -$ 121M | $ 217M |
| 2012 | $ 7.24B | -$ 4.06B | $ 207M |
| 2011 | $ 7.62B | $ 441M | $ 267M |
| 2010 | $ 7.80B | -$ 1.06B | $ 213M |
| 2009 | $ 8.18B | -$ 1.02B | $ 864M |
| 2008 | $ 8.05B | -$ 2.03B | $ 1.64B |
| 2007 | $ 8.35B | -$ 495M | $ 1.45B |
| 2006 | $ 7.82B | -$ 3.57B | $ 1.66B |
| 2005 | $ 6.28B | $ 628M | $ 848M |
| 2004 | $ 5.62B | $ 1.06B | $ 1.64B |
| 2003 | $ 3.47B | $ 472M | $ 671M |
| 2002 | $ 2.91B | $ 373M | $ 277M |
| 2001 | $ 2.67B | -$ 54M | $ 185M |
| 2000 | $ 2.66B | $ 373M | $ 60M |
| 1999 | $ 2.84B | $ 371M | $ 78M |
| 1998 | $ 2.23B | -$ 264M | $ 70M |
| 1997 | $ 1.87B | $ 139M | $ 58M |
| 1996 | $ 1.46B | $ 167M | $ 58M |
| 1995 | $ 1.10B | $ 8M | $ 115M |
| 1994 | $ 448M | $ 79M | $ 90M |
| 1993 | $ 380M | $ 69M | $ 60M |
| IPO1992 | $ 315M | $ 56M | $ 95M |
Boston Scientific Corp fundamental performance
Between 2020 and 2025, revenue grew from $ 9.91B to $ 20.07B and net income went from -$ 82M to $ 2.88B. Revenue increased in every one of those 5 years; net income in 4.
Between 2015 and 2025, revenue grew from $ 7.47B to $ 20.07B and net income went from -$ 239M to $ 2.88B. Revenue increased in 9 of those 10 years; net income in 7.
Boston Scientific Corp currently holds a 20-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.
Membership
Continue BSX’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
